ebselen has been researched along with N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Bray, W; Carlin, AF; Clark, AE; Endsley, M; Huante, MB; Huff, S; Kummetha, IR; Rana, TM; Smith, D; Tiwari, SK; Wang, S | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Dou, X; Guo, Z; Huo, T; Jiao, N; Lai, L; Liu, Y; Liu, Z; Lu, Y; Song, S; Su, L; Sun, Q; Wang, B; Wang, C; Xu, G; Yu, Z; Zhang, C; Zhang, L; Zhao, X | 1 |
| Cheng, Y; Claff, T; Gao, S; Gütschow, M; Jing, L; Kang, D; Liu, X; Müller, CE; Schäkel, L; Song, L; Sträter, N; Sylvester, K; Tavis, J; Tollefson, AE; Toth, K; Weiße, RH; Woodson, M; Yang, M; Ye, B; Zhan, P; Zhang, T | 1 |
1 review(s) available for ebselen and N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
4 other study(ies) available for ebselen and N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide
| Article | Year |
|---|---|
Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
Topics: Animals; Antiviral Agents; Benzothiazoles; Chlorocebus aethiops; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Crystallography, X-Ray; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Fluorescence Resonance Energy Transfer; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; SARS-CoV-2; Vero Cells; Virus Replication | 2022 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease.
Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Drug Discovery; Furans; Humans; Hydrazines; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2 | 2022 |
Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; COVID-19; Humans; Molecular Docking Simulation; Piperazines; Protease Inhibitors; SARS-CoV-2; Viral Nonstructural Proteins | 2022 |